tiprankstipranks
Trending News
More News >
Nissan Chemical Corporation (JP:4021)
:4021

Nissan Chemical (4021) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Nissan Chemical

(Frankfurt:4021)

71Outperform
Nissan Chemical's strong financial performance, supported by efficient operations and solid cash flow, underpins a high score. However, the current bearish technical indicators somewhat offset these positives. The stock's valuation metrics, including a low P/E ratio and high dividend yield, present a compelling case for value and income investors, contributing positively to the overall score.

Nissan Chemical (4021) vs. S&P 500 (SPY)

Nissan Chemical Business Overview & Revenue Model

Company DescriptionNissan Chemical Corporation, established in 1887 and headquartered in Tokyo, Japan, operates in the chemical industry. The company is involved in the development, manufacture, and sale of chemicals, performance materials, agricultural chemicals, and pharmaceutical products. Its core business sectors include basic chemicals, performance materials, agricultural chemicals, and pharmaceuticals. Nissan Chemical is recognized for its innovation and technological advancements, offering a diverse range of products and solutions that cater to various industrial and consumer applications.
How the Company Makes MoneyNissan Chemical generates revenue through a diversified business model that encompasses several key segments. The basic chemicals segment produces and sells products such as melamine, sulfuric acid, nitric acid, and ammonia, which are essential raw materials for various industries. The performance materials segment focuses on high-value-added products like display materials, semiconductor materials, and inorganic materials, which are critical components in electronics and other advanced technologies. The agricultural chemicals division provides herbicides, fungicides, and insecticides, contributing significantly to the company's earnings by addressing global agricultural needs. Additionally, the pharmaceuticals segment involves the development and sale of active pharmaceutical ingredients and intermediates, capitalizing on partnerships with major pharmaceutical companies. Nissan Chemical's revenue is further supported by its emphasis on innovation, research and development, and strategic collaborations that enhance its product offerings and market reach.

Nissan Chemical Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
Breakdown
TTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
246.20B226.71B228.06B207.97B209.12B206.84B
Gross Profit
114.46B104.78B106.80B101.09B87.75B84.46B
EBIT
55.85B48.20B52.28B50.96B42.53B38.65B
EBITDA
70.26B62.00B63.26B61.18B52.95B49.19B
Net Income Common Stockholders
43.77B38.03B41.09B38.78B33.47B30.78B
Balance SheetCash, Cash Equivalents and Short-Term Investments
29.20B22.74B29.65B34.66B32.38B30.64B
Total Assets
329.76B323.46B298.71B279.69B265.51B249.52B
Total Debt
47.65B40.98B27.29B22.71B22.67B24.61B
Net Debt
18.45B18.24B-2.36B-11.94B-9.71B-6.03B
Total Liabilities
100.95B92.56B77.19B71.68B64.95B64.00B
Stockholders Equity
225.63B227.47B218.42B205.91B198.83B183.92B
Cash FlowFree Cash Flow
30.07B12.70B15.05B29.10B30.40B25.97B
Operating Cash Flow
47.36B33.70B35.23B41.95B39.94B35.55B
Investing Cash Flow
-20.17B-18.74B-19.64B-12.39B-12.85B-15.62B
Financing Cash Flow
-23.55B-22.10B-25.03B-27.87B-25.63B-25.19B

Nissan Chemical Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4296.00
Price Trends
50DMA
4258.95
Positive
100DMA
4458.52
Negative
200DMA
4695.27
Negative
Market Momentum
MACD
-1.34
Negative
RSI
56.95
Neutral
STOCH
76.47
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4021, the sentiment is Positive. The current price of 4296 is above the 20-day moving average (MA) of 4123.55, above the 50-day MA of 4258.95, and below the 200-day MA of 4695.27, indicating a neutral trend. The MACD of -1.34 indicates Negative momentum. The RSI at 56.95 is Neutral, neither overbought nor oversold. The STOCH value of 76.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4021.

Nissan Chemical Peers Comparison

Overall Rating
UnderperformOutperform
Sector (49)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥203.41B8.709.01%3.42%0.32%31.76%
71
Outperform
€585.06B13.5519.18%3.87%9.83%22.31%
67
Neutral
$1.04T13.834.16%4.27%<0.01%-58.95%
64
Neutral
$625.16B12.375.83%4.49%5.15%-8.48%
59
Neutral
€165.87B15.153.51%5.41%1.62%45.83%
51
Neutral
$585.47B-16.55%2.16%4.08%-6.32%
49
Neutral
$1.97B-1.18-21.24%3.71%1.29%-31.16%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4021
Nissan Chemical
4,296.00
-725.49
-14.45%
JP:4061
Denka Co
1,941.50
-304.70
-13.57%
JP:4043
Tokuyama
2,835.50
-166.02
-5.53%
JP:4183
Mitsui Chemicals
3,288.00
-990.45
-23.15%
JP:4005
Sumitomo Chemical Co
358.90
22.40
6.66%
JP:4188
Mitsubishi Chemical Holdings
730.00
-154.48
-17.47%

Nissan Chemical Corporate Events

Nissan Chemical Completes Share Repurchase Program
Apr 18, 2025

Nissan Chemical Corporation has completed the repurchase of its own shares, acquiring a total of 695,400 shares for nearly 3 billion yen. This strategic move, executed on the Tokyo Stock Exchange, is part of a broader plan approved by the Board of Directors to enhance shareholder value and optimize capital structure.

Nissan Chemical Announces Share Repurchase Strategy
Apr 2, 2025

Nissan Chemical Corporation has repurchased 330,000 of its own common shares from the market, amounting to a total purchase cost of 1,500,769,800 yen. This move is part of a broader strategy authorized by the Board of Directors to repurchase up to 750,000 shares, with a total budget of 3,000,000,000 yen, aimed at enhancing shareholder value and optimizing capital structure.

Nissan Chemical to Repurchase Shares for Capital Flexibility
Mar 6, 2025

Nissan Chemical Corporation announced a decision to repurchase up to 750,000 of its own shares, representing 0.55% of the total shares outstanding, for up to 3 billion yen. This move is aimed at facilitating a flexible capital policy in response to changes in the business environment, potentially impacting the company’s financial strategy and market positioning.

Nissan Chemical to Cancel 1 Million Treasury Shares
Feb 26, 2025

Nissan Chemical Corporation announced the cancellation of 1,000,000 of its common shares, representing 0.73% of its issued shares, as part of a strategic move approved by its Board of Directors. This decision, scheduled to take effect on March 12, 2025, is expected to optimize the company’s capital structure and potentially enhance shareholder value.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.